Documented safety problems with compounded semaglutide consist of dosing glitches from incorrect compounding or mislabeling, contamination with microbes or other damaging substances during planning, existence of impurities or unintended substances, use of non-pharmaceutical grade Energetic elements from unregistered suppliers, and inconsistent pote